These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2619422)
41. Intropic effects of several antiarrhythmic drugs. Ferro G; Chiariello M; Tari MG; Vigorito C; Ungaro B; Condorelli M Jpn Heart J; 1983 May; 24(3):377-90. PubMed ID: 6876382 [TBL] [Abstract][Full Text] [Related]
42. Electrophysiology and pharmacology of aprindine, encainide, and propafenone. Zipes DP; Prystowsky EN; Heger JJ Ann N Y Acad Sci; 1984; 432():201-9. PubMed ID: 6441495 [No Abstract] [Full Text] [Related]
43. Effects of the Selective Stretch-Activated Channel Blocker GsMtx4 on Stretch-Induced Changes in Refractoriness in Isolated Rat Hearts and on Ventricular Premature Beats and Arrhythmias after Coronary Occlusion in Swine. Barrabés JA; Inserte J; Agulló L; Rodríguez-Sinovas A; Alburquerque-Béjar JJ; Garcia-Dorado D PLoS One; 2015; 10(5):e0125753. PubMed ID: 25938516 [TBL] [Abstract][Full Text] [Related]
44. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia. Levites R; Anderson GJ Am Heart J; 1979 Sep; 98(3):339-44. PubMed ID: 474380 [TBL] [Abstract][Full Text] [Related]
45. Electrophysiological effects of aprindine on A-V conduction in the dog. Ferrero Cabedo JA; Insa Pérez LD; López Merino V; Botella Solana S; Brugger Auban A; Esplugues Requena J Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):154-63. PubMed ID: 747461 [No Abstract] [Full Text] [Related]
46. Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. Patterson E; Gibson JK; Lucchesi BR Am J Cardiol; 1980 Nov; 46(5):792-9. PubMed ID: 7435389 [TBL] [Abstract][Full Text] [Related]
47. Responses to ligation of a coronary artery in conscious rats and the actions of antiarrhythmics. Johnston KM; MacLeod BA; Walker MJ Can J Physiol Pharmacol; 1983 Nov; 61(11):1340-53. PubMed ID: 6661688 [TBL] [Abstract][Full Text] [Related]
48. Frequency dependent effects of class I antiarrhythmic agents studied in patients with implanted pacemakers. Takanaka C; Lee JK; Nonokawa M; Sugiyama T; Yame S Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2100-5. PubMed ID: 7845825 [TBL] [Abstract][Full Text] [Related]
49. The utility of aprindine blood levels in the management of ventricular arrhythmias. Vlay SC; Kallman CH; Reid PR J Am Coll Cardiol; 1985 Mar; 5(3):738-43. PubMed ID: 3973273 [TBL] [Abstract][Full Text] [Related]
50. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion. Van Gilst WH; De Graeff PA; Kingma JH; Wesseling H; De Langen CD Eur J Pharmacol; 1984 Apr; 100(1):113-7. PubMed ID: 6373306 [TBL] [Abstract][Full Text] [Related]
51. Ischemia- and reperfusion-induced arrhythmias are prevented by putrescine. Tagliavini S; Genedani S; Bertolini A; Bazzani C Eur J Pharmacol; 1991 Feb; 194(1):7-10. PubMed ID: 2060593 [TBL] [Abstract][Full Text] [Related]
52. The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs. Marshall RJ; Parratt JR Br J Pharmacol; 1979 Jun; 66(2):241-50. PubMed ID: 465877 [TBL] [Abstract][Full Text] [Related]
53. Electrophysiologic, antiarrhythmic, and cardioprotective effects of N-[3,5 dichlorophenyl] 4-[4-hydroxy-2-methoxy-phenyl] piperazine carboxamidine dihydrochloride (RS-87337). Dumez D; Patmore L; Ferrandon P; Allely M; Armstrong JM J Cardiovasc Pharmacol; 1989 Aug; 14(2):184-93. PubMed ID: 2476590 [TBL] [Abstract][Full Text] [Related]
54. Complex frequency-dependent interaction of class-I antiarrhythmic drugs as they affect intraventricular conduction. Lee JK; Takanaka C; Nonokawa M; Kato H; Yabe S; Kodama I; Toyama J Eur Heart J; 1995 Jun; 16(6):832-41. PubMed ID: 7588928 [TBL] [Abstract][Full Text] [Related]
55. Coronary ligation-reperfusion arrhythmia models in anesthetized rats and isolated perfused rat hearts concentration-effect relationships of lidocaine. Uematsu T; Vozeh S; Ha HR; Hof RP; Follath F J Pharmacol Methods; 1986 Aug; 16(1):53-61. PubMed ID: 3747546 [TBL] [Abstract][Full Text] [Related]
56. An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Kane KA; Parratt JR; Williams FM Br J Pharmacol; 1984 Jun; 82(2):349-57. PubMed ID: 6733362 [TBL] [Abstract][Full Text] [Related]
57. Torsade des pointes and aprindine. Sideris DA; Kontoyannis DA; Moulopoulos SD Int J Cardiol; 1985 Apr; 7(4):413-6. PubMed ID: 2580805 [TBL] [Abstract][Full Text] [Related]
58. Influence of moxaprindine treatment on ventricular arrhythmias occurring during maximal exercise stress testing. Kesteloot H; van de Werf F; Marchandise B; Sluyts R Acta Cardiol; 1979; 34(5):301-9. PubMed ID: 317204 [TBL] [Abstract][Full Text] [Related]
59. [Hemodynamic effects of disopyramide on postischemic and normal myocardium]. Hoffmeister HM; Hörmann HP; Beyer M; Seipel L Klin Wochenschr; 1990 Dec; 68(23):1178-82. PubMed ID: 2280581 [TBL] [Abstract][Full Text] [Related]
60. Effect of lorcainide, a new antiarrhythmic compound, on the changes in heart rhythm induced by intravenous injection of adenosine-5'-diphosphate in rats. De Clerck F; Van Gorp L; Xhonneux R Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):222-31. PubMed ID: 646521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]